期刊文献+

喉鳞癌Apaf-1基因表达及启动子区甲基化研究 被引量:8

Expression and Promoter Methylation of Apaf-1 Gene in Laryngeal Squamous Cell Carcinoma
下载PDF
导出
摘要 喉鳞癌细胞存在多种癌基因和抑癌基因异常 ,Apaf 1(apoptoticproteaseactivatingfactor 1)基因是诱导细胞凋亡的肿瘤抑制基因。为探讨Apaf 1基因在喉鳞癌发生中的作用 ,应用半定量PCR方法分析Apaf 1的表达用比较基因组杂交 (ComparativeGenomicHybrodization ,CGH)和杂合性丢失 (LossofHeterozygosity ,LOH)分析方法对喉鳞癌病人Apaf 1基因所在的 12 q2 2 2 3区域缺失情况进行研究 ,并用甲基化特异PCR对该基因启动子区甲基化情况进行了分析。结果表明 :11例喉鳞癌组织出现Apaf 1mRNA表达明显下调 ,占 4 0 7% (11/ 2 7) ,而 6例良性喉肿瘤未发现缺失或下调 ;CGH分析发现 ,18例喉鳞癌仅发现 2例存在 12 q2 2 2 3区域缺失 ,未发现扩增 ;LOH分析发现 ,72例喉癌组织Apaf 1基因的 5个多态位点LOH发生频率低 ,分别为 18 2 % (D12S346 )、13 9%(D12S170 6 )、18 2 % (D12S32 7)、2 2 2 % (D12S16 5 7)和 16 6 % (D12S393) ,11例出现Apaf 1mRNA下调的喉癌组织均检测到启动子区甲基化 ,而 16例Apaf 1mRNA表达未下调者仅 1例有甲基化 ,两者有显著差异 (χ2 检验 ,P=0 0 0 0 1)。通过以上结果 ,首次证实Apaf 1基因与喉鳞癌相关 ,在喉鳞癌中Apaf 1基因缺失发生率低 。 Loss of tumor suppressor genes and apoptosis-associated genes was common event in laryngeal squamous cell carcinoma (LSCC).Apaf-1(apoptotic protease activating factor-1)is a key factor in cytochrome C-dependent apoptotic pathway.To investigate the effect of Apaf-1 in progression of LSCC,we analyzed Apaf-1 from DNA and RNA levels.Semi-quantitative RT-PCR analysis of Apaf-1 mRNA showed that over 40 percent of LSCCs(11/27)were low expression compared to the para-neoplastic laryngeal tissues(PNTs).The results of CGH indicated loss in 2 of 18 cases but no amplification on chromosome 12q22-23.The LOH frequencies of D12S327,D12S1657,D12S393,D12S1706,D12S346 on 12q22-23 were 18.2%,13.6%,18.2%,22.2% and 16.6%,respectively in 72 matched samples of LSCCs and PNTs.Methylation-specific PCR displayed that all of 11 LSCCs,whose expression of Apaf-1 mRNA down-regulated,were methylated in promoter regions.In contrast,only 1 of 16 LSCCs with no changes in Apaf-1 mRNA levels was methylated(χ~2 test,P=0.0001).The results implied that abnormal expression of Apaf-1 participates in the genesis of LSCCs and decreased expression of Apaf-1 mRNA were not mainly due to the deletion of Apaf-1 gene.The Apaf-1 DNA methylation in promoter region might contribute to the decreased transcription of Apaf-1 in LSCCs.
出处 《Acta Genetica Sinica》 SCIE CAS CSCD 北大核心 2004年第12期1327-1331,共5页
基金 国家自然科学基金 (编号 :3 0 1710 0 8) 辽宁省教育厅基金 (编号 :2 0 12 10 3 4)~~
关键词 喉鳞癌 APAF-1基因 RT—PCR 杂和性丢失 比较基因组杂交 甲基化 laryngeal squamous cell carcinoma (LSCC) Apaf-1 gene semi-quantitative RT-PCR loss of heterozygosity(LOH) comparative genomic hybrodization(CGH) methylation
  • 相关文献

参考文献11

  • 1Barnard D,Lehmann K,Hoal E G,van Helden P D,Victor T C.The spectrum of mutations in TP53 in laryngeal cancer patients from a high-incidence population shows similarities to many of the known mutational hotspots.Cancer Genet Cytogenet,2003,145(2):126~132.
  • 2Yu S W,Wang H,Poitras M F,Coombs C,Bowers W J,Federoff H J,Poirier G G,Dawson T M,Dawson V L.Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor.Science,2002,297(5579):259~263.
  • 3Juvekar A S,Amonkar A J,D'cruz A K,Saikaia T,Pradhan S.Chemosensitivity of advanced larynx carcinoma cells in vitro and significance of multidrug resistance markers in these tumors.Cancer Biother Radiopharm,1998;13(2):81~87.
  • 4Johnstone R W,Ruefli A A,Lowe S W.Apoptosis: a link between cancer genetics and chemotherapy.Cell,2002,108:153~164.
  • 5郭睿,黄德亮,杨伟炎,韩东一.p53,c-myc,nm23癌基因蛋白在喉复发癌的表达及其意义[J].临床耳鼻咽喉科杂志,2003,17(3):161-163. 被引量:8
  • 6邱广斌,贺光,宫立国,赵震,潘子民,唐玉钗,孙开来.hTERT cDNA片段的克隆及其单克隆抗体与喉癌的发病机制(英文)[J].Acta Genetica Sinica,2003,30(2):109-113. 被引量:1
  • 7Soengas M S,Alarcon R M,Yoshida H,Giaccia A J,Hakem R,Mak T W,Lowe S W.Apaf-1 and Caspase-9 in p53-dependent apoptosis and tumor inhibition.Science,1999,284:156~159.
  • 8Soengas M S,Capodieci P,Polsky D,Mora J,Esteller M,Opitz-Araya X,McCombie R,Herman J G,Gerald W L,Lazebnik Y A,Cordon-Cardo C,Lowe S W.Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.Nature,2001,409:207 ~ 211.
  • 9Fu W N,Bertoni F,Kelsey S M,McElwaine S M,Cotter F E,Newland A C,Jia L.Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia.Oncogene,2003,22: 451~455.
  • 10Barnard D,Lehmann K,Hoal E G,van Helden P D,Victor T C.The spectrum of mutations in TP53 in laryngeal cancer patients from a high-incidence population shows similarities to many of the known mutational hotspots.Cancer Genet Cytogenet,2003,145(2):126~132.

二级参考文献10

  • 1Christophe R. Berney,Jia-Lin Yang,Richard J. Fisher,Pamela J. Russell,Philip J. Crowe.Overexpression of nm23 Protein Assessed by Color Video Image Analysis in Metastatic Colorectal Cancer: Correlation with Reduced Patient Survival[J].World Journal of Surgery.1998(5)
  • 2Boyle J O,John H,Koch W.The incidence of p53 mutations increases with progression of head and neck cancer[].Cancer Research.1993
  • 3Nocito A,Konoen J,Kallioniemi O P,et al.Tissue microarrays(TMAS) for high-throughput molecular pathology research[].International Journal of Cancer.2001
  • 4Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrays for high-throughput molecular profiling of tumor specimens[].Nature Medicine.1998
  • 5Paluszkiewics P,Pawlowska-Wakowicz B,Karski J.The role of nm23 protein in progression of sporadic adeno-carcinoma of the large intestine[].Wiadomosci Lekarskie.1997
  • 6Mai S.Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase[].Gene.1994
  • 7Richer J,Wagner U,Kononen J,et al.High-throughput tissue microarray analysis of cyclin E amplification and overexpression in urinary bladder cancer[].American Journal of Pathology.2001
  • 8全成实,郭晓峰.Myc基因家族在喉癌中的异常扩增及其意义[J].中华耳鼻咽喉科杂志,1998,33(5):273-275. 被引量:1
  • 9肖健云,文忠,唐发清,赵素萍,田勇泉.喉鳞癌端粒酶及其端粒酶RNA的表达[J].中国耳鼻咽喉颅底外科杂志,1999,5(2):72-75. 被引量:4
  • 10马鹤雯,张玉静,阮承迈,陈守义,张立树,马永红.人喉癌细胞端粒酶催化亚基cDNA片段的扩增与克隆[J].白求恩医科大学学报,2001,27(3):331-333. 被引量:2

共引文献7

同被引文献118

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部